Related Experiment Video
Updated: Oct 13, 2025
03:01
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
955
Ectopic Pregnancy With Low Beta-Human Chorionic Gonadotropin (HCG) Managed With Methotrexate and Progressed to
Madhumitha Prabhakaran1, Anju Beesetty2
1Obstetrics and Gynecology, Saveetha Medical College and Hospital, Chennai, IND.
Cureus
|November 18, 2021
Summary
Ectopic pregnancies are common. While methotrexate therapy is often effective, some patients with low HCG levels may rarely develop ruptured ectopic pregnancies, requiring urgent surgical intervention.
Area of Science:
- Obstetrics and Gynecology
- Emergency Medicine
Background:
- Ectopic pregnancy is a frequent emergency department diagnosis.
- Management options include expectant, medical (methotrexate), or surgical approaches.
- Treatment decisions are guided by evidence-based protocols.
Observation:
- Hemodynamically stable patients with low beta-human chorionic gonadotropin (HCG) and small masses are typically treated with methotrexate.
- A rare subset of patients may experience rupture despite low and declining HCG levels.
- These cases necessitate prompt surgical evacuation.
Findings:
- Methotrexate therapy is a standard treatment for select ectopic pregnancies.
- Ruptured ectopic pregnancy can occur even with decreasing HCG levels.
- Early surgical intervention is critical for patients with ruptured ectopic pregnancy.
Implications:
- Clinicians must remain vigilant for rare complications of methotrexate-treated ectopic pregnancies.
- Preparedness for surgical management is crucial, even in seemingly low-risk cases.
- Understanding these rare progressions can improve patient outcomes and safety in emergency obstetric care.
Related Concept Videos
01:27Ovarian Cycle
2.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.1K
01:19Mitral Valve Prolapse III: Nursing Management
55
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
55
01:07Teratogenicity
3.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K